Project
SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Navigation
Downloads
Results for EGR1_EGR4
Z-value: 1.96
Motif logo
Transcription factors associated with EGR1_EGR4
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
EGR1
|
ENSG00000120738.7 | early growth response 1 |
|
EGR4
|
ENSG00000135625.6 | early growth response 4 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| EGR1 | hg19_v2_chr5_+_137801160_137801179 | 0.54 | 1.4e-02 | Click! |
| EGR4 | hg19_v2_chr2_-_73520667_73520833 | -0.27 | 2.5e-01 | Click! |
Activity profile of EGR1_EGR4 motif
Sorted Z-values of EGR1_EGR4 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr15_+_41136216 | 15.67 |
ENST00000562057.1
ENST00000344051.4 |
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
| chr15_+_41136586 | 11.43 |
ENST00000431806.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
| chr3_+_50192833 | 11.16 |
ENST00000426511.1
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
| chr15_+_41136369 | 10.55 |
ENST00000563656.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
| chr15_+_39873268 | 9.85 |
ENST00000397591.2
ENST00000260356.5 |
THBS1
|
thrombospondin 1 |
| chr12_-_57634475 | 9.82 |
ENST00000393825.1
|
NDUFA4L2
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2 |
| chr15_+_41136734 | 8.56 |
ENST00000568580.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
| chr1_-_9189144 | 6.38 |
ENST00000414642.2
|
GPR157
|
G protein-coupled receptor 157 |
| chr1_-_209979375 | 6.37 |
ENST00000367021.3
|
IRF6
|
interferon regulatory factor 6 |
| chr3_-_185542761 | 6.31 |
ENST00000457616.2
ENST00000346192.3 |
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
| chr1_-_209979465 | 6.20 |
ENST00000542854.1
|
IRF6
|
interferon regulatory factor 6 |
| chr17_-_39781054 | 6.03 |
ENST00000463128.1
|
KRT17
|
keratin 17 |
| chr17_-_39780819 | 5.95 |
ENST00000311208.8
|
KRT17
|
keratin 17 |
| chr1_+_35246775 | 5.68 |
ENST00000373366.2
|
GJB3
|
gap junction protein, beta 3, 31kDa |
| chr3_-_185542817 | 5.68 |
ENST00000382199.2
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
| chr15_+_41136263 | 5.64 |
ENST00000568823.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
| chr1_+_6484829 | 5.59 |
ENST00000377828.1
|
ESPN
|
espin |
| chr6_+_43739697 | 5.54 |
ENST00000230480.6
|
VEGFA
|
vascular endothelial growth factor A |
| chr17_-_39780634 | 5.51 |
ENST00000577817.2
|
KRT17
|
keratin 17 |
| chr1_+_43148625 | 5.43 |
ENST00000436427.1
|
YBX1
|
Y box binding protein 1 |
| chr19_-_51472031 | 5.42 |
ENST00000391808.1
|
KLK6
|
kallikrein-related peptidase 6 |
| chr1_-_9189229 | 5.28 |
ENST00000377411.4
|
GPR157
|
G protein-coupled receptor 157 |
| chr1_+_46640750 | 5.22 |
ENST00000372003.1
|
TSPAN1
|
tetraspanin 1 |
| chr15_+_74833518 | 5.15 |
ENST00000346246.5
|
ARID3B
|
AT rich interactive domain 3B (BRIGHT-like) |
| chr19_-_51472222 | 4.86 |
ENST00000376851.3
|
KLK6
|
kallikrein-related peptidase 6 |
| chr1_-_23694794 | 4.68 |
ENST00000374608.3
|
ZNF436
|
zinc finger protein 436 |
| chr4_-_36246060 | 4.67 |
ENST00000303965.4
|
ARAP2
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 |
| chr3_+_50192457 | 4.61 |
ENST00000414301.1
ENST00000450338.1 |
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
| chr15_-_75017711 | 4.60 |
ENST00000567032.1
ENST00000564596.1 ENST00000566503.1 ENST00000395049.4 ENST00000395048.2 ENST00000379727.3 |
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1 |
| chr3_-_124774802 | 4.56 |
ENST00000311127.4
|
HEG1
|
heart development protein with EGF-like domains 1 |
| chr1_+_68150744 | 4.47 |
ENST00000370986.4
ENST00000370985.3 |
GADD45A
|
growth arrest and DNA-damage-inducible, alpha |
| chr4_-_90758227 | 4.23 |
ENST00000506691.1
ENST00000394986.1 ENST00000506244.1 ENST00000394989.2 ENST00000394991.3 |
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor) |
| chr3_+_50192499 | 4.17 |
ENST00000413852.1
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
| chr1_+_43148059 | 4.08 |
ENST00000321358.7
ENST00000332220.6 |
YBX1
|
Y box binding protein 1 |
| chr3_+_50192537 | 4.07 |
ENST00000002829.3
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
| chr19_-_2050852 | 4.05 |
ENST00000541165.1
ENST00000591601.1 |
MKNK2
|
MAP kinase interacting serine/threonine kinase 2 |
| chr12_+_77158021 | 4.03 |
ENST00000550876.1
|
ZDHHC17
|
zinc finger, DHHC-type containing 17 |
| chr2_-_98612350 | 4.02 |
ENST00000186436.5
|
TMEM131
|
transmembrane protein 131 |
| chr9_-_101017900 | 3.96 |
ENST00000375066.5
|
TBC1D2
|
TBC1 domain family, member 2 |
| chr11_-_64612041 | 3.88 |
ENST00000342711.5
|
CDC42BPG
|
CDC42 binding protein kinase gamma (DMPK-like) |
| chr2_-_27718052 | 3.85 |
ENST00000264703.3
|
FNDC4
|
fibronectin type III domain containing 4 |
| chr2_+_148778570 | 3.85 |
ENST00000407073.1
|
MBD5
|
methyl-CpG binding domain protein 5 |
| chr1_-_6321035 | 3.82 |
ENST00000377893.2
|
GPR153
|
G protein-coupled receptor 153 |
| chr2_+_14772810 | 3.80 |
ENST00000295092.2
ENST00000331243.4 |
FAM84A
|
family with sequence similarity 84, member A |
| chr8_-_75233563 | 3.80 |
ENST00000342232.4
|
JPH1
|
junctophilin 1 |
| chr15_-_41408339 | 3.65 |
ENST00000401393.3
|
INO80
|
INO80 complex subunit |
| chr6_+_12012536 | 3.64 |
ENST00000379388.2
|
HIVEP1
|
human immunodeficiency virus type I enhancer binding protein 1 |
| chr16_+_2564254 | 3.60 |
ENST00000565223.1
|
ATP6V0C
|
ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c |
| chr5_-_140998481 | 3.52 |
ENST00000518047.1
|
DIAPH1
|
diaphanous-related formin 1 |
| chr6_+_15249128 | 3.48 |
ENST00000397311.3
|
JARID2
|
jumonji, AT rich interactive domain 2 |
| chr19_+_45844018 | 3.48 |
ENST00000585434.1
|
KLC3
|
kinesin light chain 3 |
| chr4_+_154074217 | 3.43 |
ENST00000437508.2
|
TRIM2
|
tripartite motif containing 2 |
| chr16_-_68269971 | 3.41 |
ENST00000565858.1
|
ESRP2
|
epithelial splicing regulatory protein 2 |
| chr7_-_143105941 | 3.38 |
ENST00000275815.3
|
EPHA1
|
EPH receptor A1 |
| chr3_+_37903432 | 3.37 |
ENST00000443503.2
|
CTDSPL
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase-like |
| chr19_+_45843994 | 3.31 |
ENST00000391946.2
|
KLC3
|
kinesin light chain 3 |
| chr11_+_67070919 | 3.19 |
ENST00000308127.4
ENST00000308298.7 |
SSH3
|
slingshot protein phosphatase 3 |
| chr5_-_140998616 | 3.19 |
ENST00000389054.3
ENST00000398562.2 ENST00000389057.5 ENST00000398566.3 ENST00000398557.4 ENST00000253811.6 |
DIAPH1
|
diaphanous-related formin 1 |
| chr15_+_52311398 | 3.19 |
ENST00000261845.5
|
MAPK6
|
mitogen-activated protein kinase 6 |
| chr2_-_214016314 | 3.19 |
ENST00000434687.1
ENST00000374319.4 |
IKZF2
|
IKAROS family zinc finger 2 (Helios) |
| chr1_+_26606608 | 3.17 |
ENST00000319041.6
|
SH3BGRL3
|
SH3 domain binding glutamic acid-rich protein like 3 |
| chr8_-_127570603 | 3.14 |
ENST00000304916.3
|
FAM84B
|
family with sequence similarity 84, member B |
| chr12_+_107349606 | 3.11 |
ENST00000547242.1
ENST00000551489.1 ENST00000550344.1 |
C12orf23
|
chromosome 12 open reading frame 23 |
| chr3_+_184279566 | 3.07 |
ENST00000330394.2
|
EPHB3
|
EPH receptor B3 |
| chr11_+_64685026 | 3.07 |
ENST00000526559.1
|
PPP2R5B
|
protein phosphatase 2, regulatory subunit B', beta |
| chr10_-_27444143 | 3.06 |
ENST00000477432.1
|
YME1L1
|
YME1-like 1 ATPase |
| chr9_+_34989638 | 3.05 |
ENST00000453597.3
ENST00000335998.3 ENST00000312316.5 |
DNAJB5
|
DnaJ (Hsp40) homolog, subfamily B, member 5 |
| chr5_+_137801160 | 3.01 |
ENST00000239938.4
|
EGR1
|
early growth response 1 |
| chr19_+_16177826 | 2.95 |
ENST00000589897.1
|
TPM4
|
tropomyosin 4 |
| chr7_-_121036337 | 2.95 |
ENST00000426156.1
ENST00000359943.3 ENST00000412653.1 |
FAM3C
|
family with sequence similarity 3, member C |
| chr19_+_37096194 | 2.93 |
ENST00000460670.1
ENST00000292928.2 ENST00000439428.1 |
ZNF382
|
zinc finger protein 382 |
| chr1_-_63153944 | 2.90 |
ENST00000340370.5
ENST00000404627.2 ENST00000251157.5 |
DOCK7
|
dedicator of cytokinesis 7 |
| chr15_-_42783303 | 2.86 |
ENST00000565380.1
ENST00000564754.1 |
ZNF106
|
zinc finger protein 106 |
| chr3_-_13921594 | 2.86 |
ENST00000285018.4
|
WNT7A
|
wingless-type MMTV integration site family, member 7A |
| chr19_+_11071685 | 2.85 |
ENST00000541122.2
ENST00000589677.1 ENST00000444061.3 |
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 |
| chr5_+_9546306 | 2.85 |
ENST00000508179.1
|
SNHG18
|
small nucleolar RNA host gene 18 (non-protein coding) |
| chr20_+_36531499 | 2.82 |
ENST00000373458.3
ENST00000373461.4 ENST00000373459.4 |
VSTM2L
|
V-set and transmembrane domain containing 2 like |
| chr17_+_79008940 | 2.82 |
ENST00000392411.3
ENST00000575989.1 ENST00000321280.7 ENST00000428708.2 ENST00000575712.1 ENST00000575245.1 ENST00000435091.3 ENST00000321300.6 |
BAIAP2
|
BAI1-associated protein 2 |
| chr19_-_56988677 | 2.81 |
ENST00000504904.3
ENST00000292069.6 |
ZNF667
|
zinc finger protein 667 |
| chr6_-_112194484 | 2.78 |
ENST00000518295.1
ENST00000484067.2 ENST00000229470.5 ENST00000356013.2 ENST00000368678.4 ENST00000523238.1 ENST00000354650.3 |
FYN
|
FYN oncogene related to SRC, FGR, YES |
| chr6_-_139308777 | 2.76 |
ENST00000529597.1
ENST00000415951.2 ENST00000367663.4 ENST00000409812.2 |
REPS1
|
RALBP1 associated Eps domain containing 1 |
| chr11_+_67071050 | 2.74 |
ENST00000376757.5
|
SSH3
|
slingshot protein phosphatase 3 |
| chr21_+_38445539 | 2.72 |
ENST00000418766.1
ENST00000450533.1 ENST00000438055.1 ENST00000355666.1 ENST00000540756.1 ENST00000399010.1 |
TTC3
|
tetratricopeptide repeat domain 3 |
| chr1_+_65886244 | 2.71 |
ENST00000344610.8
|
LEPR
|
leptin receptor |
| chr6_+_12012170 | 2.70 |
ENST00000487103.1
|
HIVEP1
|
human immunodeficiency virus type I enhancer binding protein 1 |
| chr6_-_119670919 | 2.68 |
ENST00000368468.3
|
MAN1A1
|
mannosidase, alpha, class 1A, member 1 |
| chr3_-_47823298 | 2.67 |
ENST00000254480.5
|
SMARCC1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 |
| chr8_+_57124245 | 2.65 |
ENST00000521831.1
ENST00000355315.3 ENST00000303759.3 ENST00000517636.1 ENST00000517933.1 ENST00000518801.1 ENST00000523975.1 ENST00000396723.5 ENST00000523061.1 ENST00000521524.1 |
CHCHD7
|
coiled-coil-helix-coiled-coil-helix domain containing 7 |
| chr20_-_40247002 | 2.65 |
ENST00000373222.3
|
CHD6
|
chromodomain helicase DNA binding protein 6 |
| chr3_-_42845922 | 2.63 |
ENST00000452906.2
|
HIGD1A
|
HIG1 hypoxia inducible domain family, member 1A |
| chr8_-_57123815 | 2.62 |
ENST00000316981.3
ENST00000423799.2 ENST00000429357.2 |
PLAG1
|
pleiomorphic adenoma gene 1 |
| chr16_-_3086927 | 2.62 |
ENST00000572449.1
|
CCDC64B
|
coiled-coil domain containing 64B |
| chr5_+_9546376 | 2.58 |
ENST00000509788.1
|
SNHG18
|
small nucleolar RNA host gene 18 (non-protein coding) |
| chr19_+_11071652 | 2.58 |
ENST00000344626.4
ENST00000429416.3 |
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 |
| chr7_-_44365020 | 2.57 |
ENST00000395747.2
ENST00000347193.4 ENST00000346990.4 ENST00000258682.6 ENST00000353625.4 ENST00000421607.1 ENST00000424197.1 ENST00000502837.2 ENST00000350811.3 ENST00000395749.2 |
CAMK2B
|
calcium/calmodulin-dependent protein kinase II beta |
| chr11_-_2160611 | 2.52 |
ENST00000416167.2
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
| chr16_+_67062996 | 2.51 |
ENST00000561924.2
|
CBFB
|
core-binding factor, beta subunit |
| chr7_+_90225796 | 2.49 |
ENST00000380050.3
|
CDK14
|
cyclin-dependent kinase 14 |
| chr11_-_2160180 | 2.49 |
ENST00000381406.4
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
| chr8_+_94929077 | 2.48 |
ENST00000297598.4
ENST00000520614.1 |
PDP1
|
pyruvate dehyrogenase phosphatase catalytic subunit 1 |
| chr11_+_129939811 | 2.47 |
ENST00000345598.5
ENST00000338167.5 |
APLP2
|
amyloid beta (A4) precursor-like protein 2 |
| chr13_-_45915221 | 2.47 |
ENST00000309246.5
ENST00000379060.4 ENST00000379055.1 ENST00000527226.1 ENST00000379056.1 |
TPT1
|
tumor protein, translationally-controlled 1 |
| chr6_+_37137939 | 2.45 |
ENST00000373509.5
|
PIM1
|
pim-1 oncogene |
| chr2_+_187350883 | 2.43 |
ENST00000337859.6
|
ZC3H15
|
zinc finger CCCH-type containing 15 |
| chr11_+_129939779 | 2.41 |
ENST00000533195.1
ENST00000533713.1 ENST00000528499.1 ENST00000539648.1 ENST00000263574.5 |
APLP2
|
amyloid beta (A4) precursor-like protein 2 |
| chr18_+_33877654 | 2.36 |
ENST00000257209.4
ENST00000445677.1 ENST00000590592.1 ENST00000359247.4 |
FHOD3
|
formin homology 2 domain containing 3 |
| chr17_-_56065484 | 2.36 |
ENST00000581208.1
|
VEZF1
|
vascular endothelial zinc finger 1 |
| chr1_-_94312706 | 2.35 |
ENST00000370244.1
|
BCAR3
|
breast cancer anti-estrogen resistance 3 |
| chr17_+_8924837 | 2.34 |
ENST00000173229.2
|
NTN1
|
netrin 1 |
| chr2_-_129076151 | 2.34 |
ENST00000259241.6
|
HS6ST1
|
heparan sulfate 6-O-sulfotransferase 1 |
| chr1_+_203274639 | 2.34 |
ENST00000290551.4
|
BTG2
|
BTG family, member 2 |
| chr7_+_100797726 | 2.33 |
ENST00000429457.1
|
AP1S1
|
adaptor-related protein complex 1, sigma 1 subunit |
| chr19_+_11071546 | 2.32 |
ENST00000358026.2
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 |
| chr8_+_26149274 | 2.30 |
ENST00000522535.1
|
PPP2R2A
|
protein phosphatase 2, regulatory subunit B, alpha |
| chr5_+_150404904 | 2.30 |
ENST00000521632.1
|
GPX3
|
glutathione peroxidase 3 (plasma) |
| chr2_+_66662510 | 2.30 |
ENST00000272369.9
ENST00000407092.2 |
MEIS1
|
Meis homeobox 1 |
| chr7_+_18126557 | 2.28 |
ENST00000417496.2
|
HDAC9
|
histone deacetylase 9 |
| chr3_-_126194707 | 2.28 |
ENST00000336332.5
ENST00000389709.3 |
ZXDC
|
ZXD family zinc finger C |
| chr19_-_51568324 | 2.28 |
ENST00000595547.1
ENST00000335422.3 ENST00000595793.1 ENST00000596955.1 |
KLK13
|
kallikrein-related peptidase 13 |
| chr1_+_6508100 | 2.27 |
ENST00000461727.1
|
ESPN
|
espin |
| chr7_-_127672146 | 2.26 |
ENST00000476782.1
|
LRRC4
|
leucine rich repeat containing 4 |
| chr5_+_63461642 | 2.25 |
ENST00000296615.6
ENST00000381081.2 ENST00000389100.4 |
RNF180
|
ring finger protein 180 |
| chr15_-_43882140 | 2.24 |
ENST00000429176.1
|
PPIP5K1
|
diphosphoinositol pentakisphosphate kinase 1 |
| chr19_-_45908292 | 2.22 |
ENST00000360957.5
ENST00000592134.1 |
PPP1R13L
|
protein phosphatase 1, regulatory subunit 13 like |
| chr19_-_35992780 | 2.22 |
ENST00000593342.1
ENST00000601650.1 ENST00000408915.2 |
DMKN
|
dermokine |
| chr18_-_812231 | 2.20 |
ENST00000314574.4
|
YES1
|
v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1 |
| chr11_+_8704748 | 2.19 |
ENST00000526562.1
ENST00000525981.1 |
RPL27A
|
ribosomal protein L27a |
| chr7_+_157130214 | 2.18 |
ENST00000412557.1
ENST00000453383.1 |
DNAJB6
|
DnaJ (Hsp40) homolog, subfamily B, member 6 |
| chr4_+_81187753 | 2.18 |
ENST00000312465.7
ENST00000456523.3 |
FGF5
|
fibroblast growth factor 5 |
| chr13_-_77460525 | 2.18 |
ENST00000377474.2
ENST00000317765.2 |
KCTD12
|
potassium channel tetramerization domain containing 12 |
| chr19_-_2051223 | 2.17 |
ENST00000309340.7
ENST00000589534.1 ENST00000250896.3 ENST00000589509.1 |
MKNK2
|
MAP kinase interacting serine/threonine kinase 2 |
| chr6_+_37787704 | 2.17 |
ENST00000474522.1
|
ZFAND3
|
zinc finger, AN1-type domain 3 |
| chr22_-_30722866 | 2.15 |
ENST00000403477.3
|
TBC1D10A
|
TBC1 domain family, member 10A |
| chr1_+_65886326 | 2.15 |
ENST00000371059.3
ENST00000371060.3 ENST00000349533.6 ENST00000406510.3 |
LEPR
|
leptin receptor |
| chr10_-_105452917 | 2.13 |
ENST00000427662.2
|
SH3PXD2A
|
SH3 and PX domains 2A |
| chr16_+_1359138 | 2.13 |
ENST00000325437.5
|
UBE2I
|
ubiquitin-conjugating enzyme E2I |
| chr20_+_61569463 | 2.13 |
ENST00000266069.3
|
GID8
|
GID complex subunit 8 |
| chr10_-_12084770 | 2.13 |
ENST00000357604.5
|
UPF2
|
UPF2 regulator of nonsense transcripts homolog (yeast) |
| chrX_+_134555863 | 2.11 |
ENST00000417443.2
|
LINC00086
|
long intergenic non-protein coding RNA 86 |
| chr22_+_41777927 | 2.11 |
ENST00000266304.4
|
TEF
|
thyrotrophic embryonic factor |
| chr13_-_52026730 | 2.10 |
ENST00000420668.2
|
INTS6
|
integrator complex subunit 6 |
| chr6_+_44095347 | 2.09 |
ENST00000323267.6
|
TMEM63B
|
transmembrane protein 63B |
| chr12_-_85306594 | 2.07 |
ENST00000266682.5
|
SLC6A15
|
solute carrier family 6 (neutral amino acid transporter), member 15 |
| chr20_-_43977055 | 2.07 |
ENST00000372733.3
ENST00000537976.1 |
SDC4
|
syndecan 4 |
| chr5_+_145583107 | 2.06 |
ENST00000506502.1
|
RBM27
|
RNA binding motif protein 27 |
| chr22_+_29469100 | 2.05 |
ENST00000327813.5
ENST00000407188.1 |
KREMEN1
|
kringle containing transmembrane protein 1 |
| chr19_+_11071973 | 2.04 |
ENST00000590574.1
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 |
| chr6_+_138188378 | 2.04 |
ENST00000420009.1
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3 |
| chr4_+_89514402 | 2.04 |
ENST00000426683.1
|
HERC3
|
HECT and RLD domain containing E3 ubiquitin protein ligase 3 |
| chr4_+_184427235 | 2.02 |
ENST00000412117.1
ENST00000434682.2 |
ING2
|
inhibitor of growth family, member 2 |
| chrX_+_21959108 | 2.02 |
ENST00000457085.1
|
SMS
|
spermine synthase |
| chrX_+_117480036 | 2.01 |
ENST00000371822.5
ENST00000254029.3 ENST00000371825.3 |
WDR44
|
WD repeat domain 44 |
| chr11_-_65640198 | 1.98 |
ENST00000528176.1
|
EFEMP2
|
EGF containing fibulin-like extracellular matrix protein 2 |
| chr2_-_98612379 | 1.98 |
ENST00000425805.2
|
TMEM131
|
transmembrane protein 131 |
| chr8_-_134309335 | 1.96 |
ENST00000522890.1
ENST00000323851.7 ENST00000518176.1 ENST00000354944.5 ENST00000537882.1 ENST00000522476.1 ENST00000518066.1 ENST00000521544.1 ENST00000518480.1 ENST00000523892.1 |
NDRG1
|
N-myc downstream regulated 1 |
| chr1_+_35734562 | 1.95 |
ENST00000314607.6
ENST00000373297.2 |
ZMYM4
|
zinc finger, MYM-type 4 |
| chr12_-_49351228 | 1.95 |
ENST00000541959.1
ENST00000447318.2 |
ARF3
|
ADP-ribosylation factor 3 |
| chr6_+_35310391 | 1.93 |
ENST00000337400.2
ENST00000311565.4 ENST00000540939.1 |
PPARD
|
peroxisome proliferator-activated receptor delta |
| chr21_+_37692481 | 1.92 |
ENST00000400485.1
|
MORC3
|
MORC family CW-type zinc finger 3 |
| chr4_-_102267953 | 1.91 |
ENST00000523694.2
ENST00000507176.1 |
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme |
| chr12_-_46385811 | 1.90 |
ENST00000419565.2
|
SCAF11
|
SR-related CTD-associated factor 11 |
| chr11_+_46402583 | 1.89 |
ENST00000359803.3
|
MDK
|
midkine (neurite growth-promoting factor 2) |
| chr19_+_45844032 | 1.88 |
ENST00000589837.1
|
KLC3
|
kinesin light chain 3 |
| chr3_+_50284321 | 1.88 |
ENST00000451956.1
|
GNAI2
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
| chr9_-_35115836 | 1.87 |
ENST00000378566.1
ENST00000378554.2 ENST00000322813.5 |
FAM214B
|
family with sequence similarity 214, member B |
| chr1_-_38471156 | 1.87 |
ENST00000373016.3
|
FHL3
|
four and a half LIM domains 3 |
| chr4_-_90758118 | 1.84 |
ENST00000420646.2
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor) |
| chr1_+_154193643 | 1.84 |
ENST00000456325.1
|
UBAP2L
|
ubiquitin associated protein 2-like |
| chr2_+_191208656 | 1.84 |
ENST00000458647.1
|
INPP1
|
inositol polyphosphate-1-phosphatase |
| chr3_-_42845951 | 1.83 |
ENST00000418900.2
ENST00000430190.1 |
HIGD1A
|
HIG1 hypoxia inducible domain family, member 1A |
| chr11_-_57092381 | 1.83 |
ENST00000358252.3
|
TNKS1BP1
|
tankyrase 1 binding protein 1, 182kDa |
| chr4_+_76649753 | 1.82 |
ENST00000603759.1
|
USO1
|
USO1 vesicle transport factor |
| chr1_+_155051305 | 1.82 |
ENST00000368408.3
|
EFNA3
|
ephrin-A3 |
| chr9_-_101017862 | 1.82 |
ENST00000375064.1
ENST00000342112.5 |
TBC1D2
|
TBC1 domain family, member 2 |
| chrX_-_3631635 | 1.82 |
ENST00000262848.5
|
PRKX
|
protein kinase, X-linked |
| chr1_+_24646002 | 1.81 |
ENST00000356046.2
|
GRHL3
|
grainyhead-like 3 (Drosophila) |
| chr13_+_111365602 | 1.81 |
ENST00000333219.7
|
ING1
|
inhibitor of growth family, member 1 |
| chr1_-_33647267 | 1.81 |
ENST00000291416.5
|
TRIM62
|
tripartite motif containing 62 |
| chr19_-_37096139 | 1.80 |
ENST00000585983.1
ENST00000585960.1 ENST00000586115.1 |
ZNF529
|
zinc finger protein 529 |
| chr12_-_49351148 | 1.80 |
ENST00000398092.4
ENST00000539611.1 |
RP11-302B13.5
ARF3
|
ADP-ribosylation factor 3 ADP-ribosylation factor 3 |
| chr18_+_12288288 | 1.79 |
ENST00000586226.1
|
RP11-64C12.8
|
RP11-64C12.8 |
| chr16_+_29817841 | 1.79 |
ENST00000322945.6
ENST00000562337.1 ENST00000566906.2 ENST00000563402.1 ENST00000219782.6 |
MAZ
|
MYC-associated zinc finger protein (purine-binding transcription factor) |
| chr16_+_9185450 | 1.78 |
ENST00000327827.7
|
C16orf72
|
chromosome 16 open reading frame 72 |
| chr11_-_66104237 | 1.77 |
ENST00000530056.1
|
RIN1
|
Ras and Rab interactor 1 |
| chr1_+_24645865 | 1.77 |
ENST00000342072.4
|
GRHL3
|
grainyhead-like 3 (Drosophila) |
| chr6_+_35310312 | 1.77 |
ENST00000448077.2
ENST00000360694.3 ENST00000418635.2 ENST00000444397.1 |
PPARD
|
peroxisome proliferator-activated receptor delta |
| chrX_+_107334983 | 1.77 |
ENST00000457035.1
ENST00000545696.1 |
ATG4A
|
autophagy related 4A, cysteine peptidase |
| chr19_-_2151523 | 1.76 |
ENST00000350812.6
ENST00000355272.6 ENST00000356926.4 ENST00000345016.5 |
AP3D1
|
adaptor-related protein complex 3, delta 1 subunit |
| chr6_-_13711773 | 1.75 |
ENST00000011619.3
|
RANBP9
|
RAN binding protein 9 |
| chr11_+_46403303 | 1.75 |
ENST00000407067.1
ENST00000395565.1 |
MDK
|
midkine (neurite growth-promoting factor 2) |
| chr13_+_41635617 | 1.74 |
ENST00000542082.1
|
WBP4
|
WW domain binding protein 4 |
| chr15_+_40733387 | 1.74 |
ENST00000416165.1
|
BAHD1
|
bromo adjacent homology domain containing 1 |
| chr3_+_197477038 | 1.74 |
ENST00000426031.1
ENST00000424384.2 |
FYTTD1
|
forty-two-three domain containing 1 |
| chr17_-_47439437 | 1.74 |
ENST00000430262.2
|
ZNF652
|
zinc finger protein 652 |
| chr11_-_66103932 | 1.74 |
ENST00000311320.4
|
RIN1
|
Ras and Rab interactor 1 |
| chrX_-_135333514 | 1.73 |
ENST00000370661.1
ENST00000370660.3 |
MAP7D3
|
MAP7 domain containing 3 |
| chr13_-_52027134 | 1.72 |
ENST00000311234.4
ENST00000425000.1 ENST00000463928.1 ENST00000442263.3 ENST00000398119.2 |
INTS6
|
integrator complex subunit 6 |
| chr18_-_53255766 | 1.72 |
ENST00000566286.1
ENST00000564999.1 ENST00000566279.1 ENST00000354452.3 ENST00000356073.4 |
TCF4
|
transcription factor 4 |
| chrX_+_107334895 | 1.72 |
ENST00000372232.3
ENST00000345734.3 ENST00000372254.3 |
ATG4A
|
autophagy related 4A, cysteine peptidase |
| chr19_-_14228541 | 1.71 |
ENST00000590853.1
ENST00000308677.4 |
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha |
Network of associatons between targets according to the STRING database.
First level regulatory network of EGR1_EGR4
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.3 | 9.9 | GO:0002605 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) negative regulation of dendritic cell antigen processing and presentation(GO:0002605) negative regulation of endothelial cell chemotaxis(GO:2001027) |
| 2.0 | 51.8 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 2.0 | 9.8 | GO:0007070 | negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
| 1.8 | 5.5 | GO:0003169 | coronary vein morphogenesis(GO:0003169) regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
| 1.7 | 24.0 | GO:0035290 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
| 1.6 | 4.8 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
| 1.5 | 4.6 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 1.3 | 3.9 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 1.2 | 6.1 | GO:0051585 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
| 1.1 | 3.4 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
| 1.1 | 3.3 | GO:0070429 | regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) negative regulation of CD40 signaling pathway(GO:2000349) |
| 1.0 | 3.1 | GO:0061193 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
| 1.0 | 3.0 | GO:0050720 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) interleukin-1 beta biosynthetic process(GO:0050720) |
| 0.9 | 4.5 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
| 0.9 | 5.2 | GO:0030421 | defecation(GO:0030421) |
| 0.9 | 9.5 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.7 | 14.2 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
| 0.7 | 20.3 | GO:0045109 | intermediate filament organization(GO:0045109) |
| 0.7 | 4.6 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 0.6 | 1.8 | GO:0048007 | synaptic vesicle recycling via endosome(GO:0036466) antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.6 | 4.6 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.6 | 1.7 | GO:0061110 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 0.5 | 1.6 | GO:0051389 | inactivation of MAPKK activity(GO:0051389) trans-synaptic signaling by trans-synaptic complex(GO:0099545) |
| 0.5 | 8.1 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
| 0.5 | 3.8 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
| 0.5 | 2.7 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.5 | 2.7 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
| 0.5 | 1.6 | GO:0060733 | regulation of eIF2 alpha phosphorylation by amino acid starvation(GO:0060733) regulation of translational initiation in response to starvation(GO:0071262) positive regulation of translational initiation in response to starvation(GO:0071264) |
| 0.5 | 2.1 | GO:0090096 | regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.5 | 2.1 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 0.5 | 0.5 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
| 0.5 | 2.1 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
| 0.5 | 1.5 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
| 0.5 | 1.5 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
| 0.5 | 3.5 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.5 | 10.3 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.5 | 2.9 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.5 | 1.9 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
| 0.5 | 1.4 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
| 0.5 | 0.9 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
| 0.5 | 5.0 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.5 | 2.3 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
| 0.4 | 1.8 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.4 | 2.6 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
| 0.4 | 1.3 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
| 0.4 | 1.3 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
| 0.4 | 1.3 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 0.4 | 3.8 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
| 0.4 | 2.5 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.4 | 7.0 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.4 | 1.2 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.4 | 2.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.4 | 1.2 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
| 0.4 | 3.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
| 0.4 | 3.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.4 | 4.9 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.4 | 4.3 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
| 0.4 | 7.1 | GO:0090178 | regulation of establishment of planar polarity involved in neural tube closure(GO:0090178) |
| 0.3 | 1.7 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.3 | 1.0 | GO:0008057 | eye pigment granule organization(GO:0008057) |
| 0.3 | 3.1 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
| 0.3 | 2.7 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 0.3 | 3.7 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
| 0.3 | 2.3 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 0.3 | 3.6 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.3 | 3.5 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
| 0.3 | 2.2 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 0.3 | 4.4 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.3 | 0.9 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
| 0.3 | 1.5 | GO:0032796 | uropod organization(GO:0032796) |
| 0.3 | 2.1 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.3 | 1.5 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.3 | 0.9 | GO:0071106 | coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
| 0.3 | 0.9 | GO:1904717 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.3 | 2.4 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.3 | 1.2 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.3 | 0.6 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
| 0.3 | 0.9 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
| 0.3 | 2.3 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
| 0.3 | 0.9 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
| 0.3 | 1.1 | GO:0043400 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) intestinal epithelial cell migration(GO:0061582) |
| 0.3 | 1.1 | GO:0031052 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) positive regulation of cellular response to X-ray(GO:2000685) |
| 0.3 | 1.9 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
| 0.3 | 1.9 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
| 0.3 | 6.2 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.3 | 2.9 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.3 | 1.3 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.3 | 5.8 | GO:0021542 | dentate gyrus development(GO:0021542) |
| 0.3 | 2.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.3 | 1.0 | GO:0035397 | helper T cell enhancement of adaptive immune response(GO:0035397) |
| 0.3 | 0.5 | GO:1901656 | glycoside transport(GO:1901656) |
| 0.3 | 0.8 | GO:0097198 | histone H3-K36 trimethylation(GO:0097198) |
| 0.3 | 2.5 | GO:1901314 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
| 0.2 | 0.7 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 0.2 | 2.0 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
| 0.2 | 0.5 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.2 | 1.2 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.2 | 1.4 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.2 | 2.4 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 0.2 | 0.7 | GO:1990922 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 0.2 | 0.7 | GO:2000657 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
| 0.2 | 0.7 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
| 0.2 | 3.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.2 | 0.7 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.2 | 0.7 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.2 | 15.2 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
| 0.2 | 0.9 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
| 0.2 | 1.1 | GO:0030862 | positive regulation of polarized epithelial cell differentiation(GO:0030862) |
| 0.2 | 1.1 | GO:0030279 | negative regulation of ossification(GO:0030279) |
| 0.2 | 1.3 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 0.2 | 1.3 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 0.2 | 1.3 | GO:0003383 | apical constriction(GO:0003383) |
| 0.2 | 0.7 | GO:0021722 | pons maturation(GO:0021586) superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.2 | 2.3 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
| 0.2 | 4.9 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.2 | 0.6 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 0.2 | 3.2 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
| 0.2 | 2.1 | GO:0015820 | leucine transport(GO:0015820) |
| 0.2 | 2.3 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
| 0.2 | 4.9 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
| 0.2 | 6.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.2 | 0.4 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
| 0.2 | 1.6 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.2 | 1.8 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 0.2 | 2.8 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
| 0.2 | 0.6 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.2 | 4.3 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
| 0.2 | 3.7 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
| 0.2 | 1.7 | GO:0051258 | protein polymerization(GO:0051258) |
| 0.2 | 1.1 | GO:0051414 | response to cortisol(GO:0051414) |
| 0.2 | 0.6 | GO:0045083 | negative regulation of interleukin-12 biosynthetic process(GO:0045083) |
| 0.2 | 3.6 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
| 0.2 | 0.4 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
| 0.2 | 0.9 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.2 | 2.4 | GO:1902961 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.2 | 0.9 | GO:1904628 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.2 | 1.5 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.2 | 3.3 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.2 | 1.1 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.2 | 0.5 | GO:0061145 | bronchus cartilage development(GO:0060532) lung smooth muscle development(GO:0061145) |
| 0.2 | 0.9 | GO:0001649 | osteoblast differentiation(GO:0001649) |
| 0.2 | 1.1 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 0.2 | 1.1 | GO:1901910 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.2 | 0.9 | GO:2000690 | regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.2 | 0.7 | GO:1905123 | regulation of endosome organization(GO:1904978) regulation of glucosylceramidase activity(GO:1905123) |
| 0.2 | 0.5 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
| 0.2 | 0.9 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 0.2 | 1.7 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.2 | 1.4 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.2 | 0.7 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
| 0.2 | 0.7 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
| 0.2 | 1.2 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
| 0.2 | 1.2 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
| 0.2 | 2.6 | GO:0060736 | prostate gland growth(GO:0060736) |
| 0.2 | 1.1 | GO:1902162 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.2 | 0.3 | GO:0043634 | polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
| 0.2 | 0.6 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.2 | 1.9 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.2 | 0.9 | GO:0072104 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.2 | 1.7 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.2 | 0.9 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
| 0.2 | 1.4 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 0.2 | 0.5 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
| 0.2 | 1.1 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
| 0.2 | 1.1 | GO:1904721 | negative regulation of mRNA cleavage(GO:0031438) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
| 0.2 | 2.3 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.2 | 1.4 | GO:0046836 | glycolipid transport(GO:0046836) |
| 0.2 | 1.5 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
| 0.2 | 0.6 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 0.1 | 1.3 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
| 0.1 | 4.4 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
| 0.1 | 0.9 | GO:2000489 | regulation of hepatic stellate cell activation(GO:2000489) |
| 0.1 | 1.3 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
| 0.1 | 1.3 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
| 0.1 | 0.7 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 0.1 | 0.6 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.1 | 0.4 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.1 | 1.4 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.1 | 0.6 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 0.1 | 0.8 | GO:0042256 | mature ribosome assembly(GO:0042256) |
| 0.1 | 0.7 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.1 | 1.4 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.1 | 0.7 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
| 0.1 | 2.3 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 0.1 | 0.7 | GO:0043335 | protein unfolding(GO:0043335) |
| 0.1 | 0.3 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.1 | 2.4 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.1 | 2.3 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.1 | 0.7 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
| 0.1 | 0.4 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.1 | 1.4 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
| 0.1 | 1.4 | GO:0061458 | reproductive system development(GO:0061458) |
| 0.1 | 3.2 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.1 | 1.1 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
| 0.1 | 0.7 | GO:0001880 | Mullerian duct regression(GO:0001880) |
| 0.1 | 0.4 | GO:0007388 | anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
| 0.1 | 2.0 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
| 0.1 | 0.4 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
| 0.1 | 0.9 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.1 | 0.4 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.1 | 0.7 | GO:0002317 | plasma cell differentiation(GO:0002317) |
| 0.1 | 2.0 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.1 | 3.2 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.1 | 3.2 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
| 0.1 | 0.5 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
| 0.1 | 0.8 | GO:0044026 | DNA hypermethylation(GO:0044026) |
| 0.1 | 2.2 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.1 | 1.0 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
| 0.1 | 1.0 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 0.1 | 1.5 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.1 | 0.3 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
| 0.1 | 0.3 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 0.1 | 2.3 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 0.1 | 1.8 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
| 0.1 | 0.4 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 0.1 | 1.3 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.1 | 1.3 | GO:0016926 | protein desumoylation(GO:0016926) |
| 0.1 | 2.6 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.1 | 1.2 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.1 | 1.4 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
| 0.1 | 0.6 | GO:0072708 | response to sorbitol(GO:0072708) |
| 0.1 | 1.1 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.1 | 1.7 | GO:2001222 | regulation of neuron migration(GO:2001222) |
| 0.1 | 3.0 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.1 | 1.3 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
| 0.1 | 3.4 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
| 0.1 | 3.9 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.1 | 3.2 | GO:0022038 | corpus callosum development(GO:0022038) |
| 0.1 | 2.4 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
| 0.1 | 0.9 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.1 | 1.2 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.1 | 1.3 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
| 0.1 | 0.5 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.1 | 0.7 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.1 | 1.0 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
| 0.1 | 7.7 | GO:0008088 | axo-dendritic transport(GO:0008088) |
| 0.1 | 1.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.1 | 0.2 | GO:0090647 | modulation of age-related behavioral decline(GO:0090647) regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
| 0.1 | 1.9 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
| 0.1 | 0.4 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
| 0.1 | 0.3 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.1 | 1.7 | GO:0031507 | heterochromatin assembly(GO:0031507) |
| 0.1 | 0.6 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.1 | 1.9 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.1 | 0.5 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.1 | 0.6 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) regulation of kinetochore assembly(GO:0090234) |
| 0.1 | 0.3 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
| 0.1 | 1.0 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 0.1 | 0.3 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 0.1 | 0.9 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
| 0.1 | 1.0 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
| 0.1 | 0.4 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 0.1 | 1.2 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
| 0.1 | 0.7 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.1 | 0.5 | GO:0035799 | ureter maturation(GO:0035799) |
| 0.1 | 2.0 | GO:0006853 | carnitine shuttle(GO:0006853) |
| 0.1 | 0.2 | GO:1902824 | lysosomal membrane organization(GO:0097212) positive regulation of late endosome to lysosome transport(GO:1902824) |
| 0.1 | 3.7 | GO:1990090 | cellular response to nerve growth factor stimulus(GO:1990090) |
| 0.1 | 1.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
| 0.1 | 1.5 | GO:0030575 | nuclear body organization(GO:0030575) |
| 0.1 | 0.2 | GO:0031642 | negative regulation of myelination(GO:0031642) regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
| 0.1 | 12.0 | GO:0090630 | activation of GTPase activity(GO:0090630) |
| 0.1 | 2.1 | GO:0006337 | nucleosome disassembly(GO:0006337) |
| 0.1 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
| 0.1 | 0.8 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
| 0.1 | 0.8 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.1 | 0.6 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
| 0.1 | 8.0 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
| 0.1 | 1.8 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
| 0.1 | 1.7 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
| 0.1 | 1.8 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
| 0.1 | 1.6 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.1 | 0.5 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.1 | 0.3 | GO:0035900 | response to isolation stress(GO:0035900) |
| 0.1 | 0.8 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
| 0.1 | 0.7 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.1 | 0.5 | GO:0070672 | response to interleukin-15(GO:0070672) |
| 0.1 | 0.5 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.1 | 0.3 | GO:0060155 | platelet dense granule organization(GO:0060155) |
| 0.1 | 0.9 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
| 0.1 | 2.6 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.1 | 4.0 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.1 | 1.4 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
| 0.1 | 0.7 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
| 0.1 | 0.9 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
| 0.1 | 0.3 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.1 | 0.6 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
| 0.1 | 0.1 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
| 0.1 | 0.5 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
| 0.1 | 0.6 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.1 | 1.4 | GO:0007567 | parturition(GO:0007567) |
| 0.1 | 0.9 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.1 | 1.0 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.1 | 0.4 | GO:0045837 | negative regulation of mitochondrial membrane potential(GO:0010917) negative regulation of membrane potential(GO:0045837) |
| 0.1 | 1.8 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
| 0.1 | 2.3 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
| 0.1 | 0.3 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
| 0.1 | 4.7 | GO:0015914 | phospholipid transport(GO:0015914) |
| 0.1 | 0.2 | GO:0019417 | sulfur oxidation(GO:0019417) |
| 0.1 | 0.3 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
| 0.1 | 0.6 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
| 0.1 | 0.6 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.1 | 0.2 | GO:0034378 | chylomicron assembly(GO:0034378) |
| 0.1 | 1.9 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
| 0.1 | 1.5 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.1 | 0.4 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.1 | 0.2 | GO:0070376 | regulation of ERK5 cascade(GO:0070376) negative regulation of ERK5 cascade(GO:0070377) |
| 0.1 | 0.4 | GO:0002326 | B cell lineage commitment(GO:0002326) immunoglobulin V(D)J recombination(GO:0033152) |
| 0.1 | 0.3 | GO:0048505 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
| 0.1 | 0.3 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.1 | 0.9 | GO:0007626 | locomotory behavior(GO:0007626) |
| 0.1 | 0.8 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.1 | 0.8 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 0.1 | 0.2 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.1 | 1.2 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.1 | 0.6 | GO:0048757 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
| 0.1 | 0.7 | GO:0008105 | asymmetric protein localization(GO:0008105) |
| 0.0 | 0.8 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.0 | 0.7 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
| 0.0 | 0.2 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.0 | 0.1 | GO:0001507 | acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.0 | 0.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 0.0 | 0.4 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.0 | 0.4 | GO:0034465 | response to carbon monoxide(GO:0034465) |
| 0.0 | 1.2 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.0 | 0.7 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
| 0.0 | 0.0 | GO:0003220 | left ventricular cardiac muscle tissue morphogenesis(GO:0003220) |
| 0.0 | 0.7 | GO:0006449 | regulation of translational termination(GO:0006449) |
| 0.0 | 0.7 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.0 | 0.8 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
| 0.0 | 1.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
| 0.0 | 0.5 | GO:0006477 | protein sulfation(GO:0006477) |
| 0.0 | 0.4 | GO:0072189 | ureter development(GO:0072189) |
| 0.0 | 0.7 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.0 | 0.9 | GO:0098779 | mitophagy in response to mitochondrial depolarization(GO:0098779) |
| 0.0 | 0.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
| 0.0 | 1.0 | GO:0008340 | determination of adult lifespan(GO:0008340) |
| 0.0 | 0.7 | GO:0060828 | regulation of canonical Wnt signaling pathway(GO:0060828) |
| 0.0 | 4.8 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
| 0.0 | 0.4 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.0 | 0.3 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.0 | 0.3 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.0 | 4.1 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.0 | 2.5 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
| 0.0 | 0.9 | GO:0019054 | modulation by virus of host process(GO:0019054) |
| 0.0 | 0.7 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.0 | 0.6 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
| 0.0 | 0.7 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.0 | 0.2 | GO:0006404 | RNA import into nucleus(GO:0006404) snRNA import into nucleus(GO:0061015) |
| 0.0 | 1.0 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
| 0.0 | 0.6 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.0 | 1.6 | GO:0035666 | TRIF-dependent toll-like receptor signaling pathway(GO:0035666) |
| 0.0 | 0.1 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.0 | 0.5 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
| 0.0 | 1.3 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
| 0.0 | 0.2 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.0 | 0.7 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.0 | 0.2 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
| 0.0 | 1.0 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
| 0.0 | 3.4 | GO:0045454 | cell redox homeostasis(GO:0045454) |
| 0.0 | 1.1 | GO:0060042 | retina morphogenesis in camera-type eye(GO:0060042) |
| 0.0 | 0.5 | GO:0040013 | negative regulation of locomotion(GO:0040013) |
| 0.0 | 0.1 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) negative regulation of fatty acid beta-oxidation(GO:0031999) |
| 0.0 | 0.3 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
| 0.0 | 0.7 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
| 0.0 | 1.0 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
| 0.0 | 0.8 | GO:0010996 | response to auditory stimulus(GO:0010996) |
| 0.0 | 2.0 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.0 | 0.2 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 0.0 | 0.5 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
| 0.0 | 0.2 | GO:0034486 | vacuolar transmembrane transport(GO:0034486) chaperone-mediated protein transport involved in chaperone-mediated autophagy(GO:0061741) negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
| 0.0 | 2.4 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.0 | 5.8 | GO:0002576 | platelet degranulation(GO:0002576) |
| 0.0 | 0.2 | GO:0002347 | response to tumor cell(GO:0002347) |
| 0.0 | 1.1 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.0 | 0.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.0 | 0.5 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.0 | 0.6 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.0 | 5.7 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.0 | 2.9 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
| 0.0 | 0.4 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
| 0.0 | 0.6 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
| 0.0 | 0.5 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
| 0.0 | 0.4 | GO:0051402 | neuron apoptotic process(GO:0051402) |
| 0.0 | 0.8 | GO:0006783 | heme biosynthetic process(GO:0006783) |
| 0.0 | 0.9 | GO:0031648 | protein destabilization(GO:0031648) |
| 0.0 | 0.9 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.0 | 0.6 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.0 | 0.2 | GO:0009299 | mRNA transcription(GO:0009299) |
| 0.0 | 1.1 | GO:1903146 | regulation of mitophagy(GO:1903146) |
| 0.0 | 0.9 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
| 0.0 | 3.9 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
| 0.0 | 0.3 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.0 | 0.1 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
| 0.0 | 0.7 | GO:0050779 | RNA destabilization(GO:0050779) |
| 0.0 | 0.6 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
| 0.0 | 0.6 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
| 0.0 | 2.4 | GO:0001523 | retinoid metabolic process(GO:0001523) |
| 0.0 | 0.2 | GO:0055048 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
| 0.0 | 0.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.0 | 0.2 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.0 | 0.4 | GO:1904903 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.0 | 0.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 0.0 | 0.6 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
| 0.0 | 0.1 | GO:0006801 | superoxide metabolic process(GO:0006801) |
| 0.0 | 0.7 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
| 0.0 | 0.6 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.0 | 0.1 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) response to methylglyoxal(GO:0051595) regulation of histone H3-K27 acetylation(GO:1901674) negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.0 | 0.4 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.0 | 1.5 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
| 0.0 | 0.1 | GO:0052551 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 0.0 | 0.5 | GO:0071539 | protein localization to centrosome(GO:0071539) |
| 0.0 | 0.4 | GO:0043487 | regulation of RNA stability(GO:0043487) |
| 0.0 | 0.0 | GO:0072520 | seminiferous tubule development(GO:0072520) |
| 0.0 | 0.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.0 | 0.5 | GO:0090382 | phagosome maturation(GO:0090382) |
| 0.0 | 0.7 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
| 0.0 | 0.2 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
| 0.0 | 2.1 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
| 0.0 | 0.3 | GO:0035878 | nail development(GO:0035878) |
| 0.0 | 0.1 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.0 | 0.5 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.0 | 0.4 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.0 | 1.0 | GO:0043171 | peptide catabolic process(GO:0043171) |
| 0.0 | 0.0 | GO:0042418 | epinephrine metabolic process(GO:0042414) epinephrine biosynthetic process(GO:0042418) |
| 0.0 | 0.7 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.0 | 0.5 | GO:0061053 | somite development(GO:0061053) |
| 0.0 | 0.3 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
| 0.0 | 2.3 | GO:0070268 | cornification(GO:0070268) |
| 0.0 | 0.2 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
| 0.0 | 0.0 | GO:0070295 | renal water absorption(GO:0070295) |
| 0.0 | 0.2 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
| 0.0 | 0.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
| 0.0 | 0.2 | GO:0051382 | kinetochore assembly(GO:0051382) |
| 0.0 | 0.4 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.0 | 0.2 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
| 0.0 | 0.4 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
| 0.0 | 0.6 | GO:1901998 | toxin transport(GO:1901998) |
| 0.0 | 0.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.0 | 0.9 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
| 0.0 | 0.7 | GO:0009060 | aerobic respiration(GO:0009060) |
| 0.0 | 0.8 | GO:1903391 | regulation of adherens junction organization(GO:1903391) |
| 0.0 | 0.2 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.0 | 0.1 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
| 0.0 | 0.3 | GO:0016032 | viral process(GO:0016032) |
| 0.0 | 1.0 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.0 | 0.5 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.0 | 9.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.7 | 9.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.6 | 10.5 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.6 | 2.4 | GO:0031213 | RSF complex(GO:0031213) |
| 0.6 | 9.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.5 | 8.1 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.5 | 4.3 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.5 | 13.1 | GO:0071564 | npBAF complex(GO:0071564) |
| 0.5 | 3.2 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.4 | 2.5 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 0.4 | 2.7 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
| 0.4 | 0.4 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.4 | 1.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
| 0.4 | 2.5 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.3 | 3.3 | GO:0016589 | NURF complex(GO:0016589) |
| 0.3 | 1.3 | GO:0032420 | stereocilium(GO:0032420) |
| 0.3 | 1.0 | GO:0002139 | stereocilia coupling link(GO:0002139) |
| 0.3 | 0.9 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
| 0.3 | 12.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.3 | 0.8 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
| 0.3 | 0.8 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
| 0.3 | 4.0 | GO:0032039 | integrator complex(GO:0032039) |
| 0.2 | 0.7 | GO:0000806 | Y chromosome(GO:0000806) |
| 0.2 | 3.2 | GO:0044309 | dendritic spine(GO:0043197) neuron spine(GO:0044309) |
| 0.2 | 6.0 | GO:0005922 | connexon complex(GO:0005922) |
| 0.2 | 1.7 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 0.2 | 1.0 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
| 0.2 | 2.3 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 0.2 | 1.4 | GO:0032437 | cuticular plate(GO:0032437) |
| 0.2 | 0.7 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.2 | 1.0 | GO:0000799 | nuclear condensin complex(GO:0000799) |
| 0.2 | 3.0 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.2 | 0.7 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 0.2 | 1.5 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
| 0.2 | 0.8 | GO:0071942 | XPC complex(GO:0071942) |
| 0.2 | 5.0 | GO:0016580 | Sin3 complex(GO:0016580) |
| 0.2 | 0.5 | GO:0098844 | postsynaptic endocytic zone membrane(GO:0098844) |
| 0.2 | 1.1 | GO:0072589 | box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
| 0.2 | 4.8 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.2 | 0.6 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.1 | 1.3 | GO:0016013 | syntrophin complex(GO:0016013) |
| 0.1 | 1.3 | GO:0051286 | cell tip(GO:0051286) |
| 0.1 | 0.6 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
| 0.1 | 0.4 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
| 0.1 | 2.5 | GO:0097433 | dense body(GO:0097433) |
| 0.1 | 1.7 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.1 | 0.9 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 0.1 | 3.9 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.1 | 4.8 | GO:0005682 | U5 snRNP(GO:0005682) |
| 0.1 | 1.0 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
| 0.1 | 2.4 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.1 | 0.9 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 0.1 | 2.4 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.1 | 1.1 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.1 | 3.6 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.1 | 3.3 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.1 | 1.8 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 0.1 | 0.5 | GO:0044291 | cell-cell contact zone(GO:0044291) |
| 0.1 | 0.3 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 0.1 | 4.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.1 | 0.7 | GO:0071546 | pi-body(GO:0071546) |
| 0.1 | 0.3 | GO:0016514 | SWI/SNF complex(GO:0016514) |
| 0.1 | 0.9 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
| 0.1 | 1.6 | GO:0005916 | fascia adherens(GO:0005916) |
| 0.1 | 1.0 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.1 | 1.3 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
| 0.1 | 1.0 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.1 | 1.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.1 | 2.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.1 | 2.1 | GO:0070160 | bicellular tight junction(GO:0005923) apical junction complex(GO:0043296) occluding junction(GO:0070160) |
| 0.1 | 1.2 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.1 | 1.0 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 0.1 | 2.7 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.1 | 0.9 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.1 | 2.8 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 0.1 | 1.7 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.1 | 0.9 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.1 | 0.7 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
| 0.1 | 2.0 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.1 | 2.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.1 | 1.4 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.1 | 0.9 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.1 | 0.8 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.1 | 0.7 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 0.1 | 2.0 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.1 | 1.5 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.1 | 3.9 | GO:0043034 | costamere(GO:0043034) |
| 0.1 | 11.5 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.1 | 2.4 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.1 | 2.0 | GO:0010369 | chromocenter(GO:0010369) |
| 0.1 | 1.0 | GO:0001939 | female pronucleus(GO:0001939) |
| 0.1 | 7.3 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.1 | 0.3 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
| 0.1 | 2.6 | GO:0032156 | septin cytoskeleton(GO:0032156) |
| 0.1 | 0.9 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.1 | 0.5 | GO:0000805 | X chromosome(GO:0000805) Barr body(GO:0001740) |
| 0.1 | 7.9 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.1 | 0.4 | GO:0001673 | male germ cell nucleus(GO:0001673) |
| 0.1 | 3.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.1 | 2.4 | GO:0005865 | striated muscle thin filament(GO:0005865) |
| 0.1 | 2.8 | GO:0000795 | synaptonemal complex(GO:0000795) |
| 0.1 | 0.4 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 0.1 | 1.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.1 | 1.9 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.1 | 0.8 | GO:0005921 | gap junction(GO:0005921) |
| 0.1 | 2.1 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.1 | 0.7 | GO:0034709 | methylosome(GO:0034709) |
| 0.1 | 0.7 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 0.1 | 3.4 | GO:0002102 | podosome(GO:0002102) |
| 0.1 | 0.6 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.1 | 0.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.1 | 0.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.1 | 0.6 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.1 | 0.5 | GO:0030478 | actin cap(GO:0030478) |
| 0.1 | 0.2 | GO:0033268 | node of Ranvier(GO:0033268) |
| 0.1 | 3.8 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.1 | 0.8 | GO:0097470 | ribbon synapse(GO:0097470) |
| 0.1 | 0.4 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.0 | 5.8 | GO:0060170 | ciliary membrane(GO:0060170) |
| 0.0 | 0.4 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
| 0.0 | 0.5 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
| 0.0 | 0.6 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 0.0 | 0.9 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 0.0 | 0.8 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.0 | 7.4 | GO:0016605 | PML body(GO:0016605) |
| 0.0 | 0.5 | GO:0042589 | zymogen granule membrane(GO:0042589) |
| 0.0 | 1.1 | GO:0042627 | chylomicron(GO:0042627) |
| 0.0 | 0.2 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 0.0 | 3.1 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.0 | 1.7 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.0 | 1.8 | GO:0097228 | sperm principal piece(GO:0097228) |
| 0.0 | 2.9 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.0 | 0.9 | GO:0036020 | endolysosome(GO:0036019) endolysosome membrane(GO:0036020) |
| 0.0 | 0.5 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
| 0.0 | 0.4 | GO:0000243 | commitment complex(GO:0000243) |
| 0.0 | 0.9 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.0 | 0.6 | GO:0061700 | GATOR2 complex(GO:0061700) |
| 0.0 | 0.6 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.0 | 0.7 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.0 | 0.5 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
| 0.0 | 2.3 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
| 0.0 | 2.2 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.0 | 0.9 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.0 | 5.2 | GO:0005884 | actin filament(GO:0005884) |
| 0.0 | 0.8 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.0 | 0.1 | GO:0089701 | U2AF(GO:0089701) |
| 0.0 | 3.5 | GO:0070469 | respiratory chain(GO:0070469) |
| 0.0 | 1.7 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
| 0.0 | 0.3 | GO:0070552 | BRCA1-A complex(GO:0070531) BRISC complex(GO:0070552) |
| 0.0 | 2.4 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.0 | 0.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 0.0 | 2.5 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.0 | 0.2 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.0 | 1.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.0 | 0.5 | GO:0097539 | ciliary transition fiber(GO:0097539) |
| 0.0 | 0.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.0 | 0.2 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
| 0.0 | 2.5 | GO:0043195 | terminal bouton(GO:0043195) |
| 0.0 | 4.8 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.0 | 2.5 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.0 | 0.2 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
| 0.0 | 3.8 | GO:0016604 | nuclear body(GO:0016604) |
| 0.0 | 2.6 | GO:0016363 | nuclear matrix(GO:0016363) |
| 0.0 | 0.3 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
| 0.0 | 0.3 | GO:0072487 | MSL complex(GO:0072487) |
| 0.0 | 0.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.0 | 3.0 | GO:0036064 | ciliary basal body(GO:0036064) |
| 0.0 | 12.1 | GO:0016607 | nuclear speck(GO:0016607) |
| 0.0 | 1.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.0 | 0.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.0 | 38.1 | GO:0005615 | extracellular space(GO:0005615) |
| 0.0 | 3.1 | GO:0005604 | basement membrane(GO:0005604) |
| 0.0 | 1.1 | GO:0014704 | intercalated disc(GO:0014704) |
| 0.0 | 0.6 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.0 | 1.4 | GO:0005902 | microvillus(GO:0005902) |
| 0.0 | 0.1 | GO:0000235 | astral microtubule(GO:0000235) aster(GO:0005818) |
| 0.0 | 0.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.0 | 0.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.0 | 0.6 | GO:0015030 | Cajal body(GO:0015030) |
| 0.0 | 2.9 | GO:0031674 | I band(GO:0031674) |
| 0.0 | 1.8 | GO:0043204 | perikaryon(GO:0043204) |
| 0.0 | 0.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.0 | 1.0 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.0 | 1.1 | GO:0005813 | centrosome(GO:0005813) |
| 0.0 | 1.6 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.0 | 0.8 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 0.0 | 0.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.0 | 0.9 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
| 0.0 | 0.3 | GO:0030057 | desmosome(GO:0030057) |
| 0.0 | 0.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.0 | 0.8 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.0 | 1.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.0 | 0.2 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
| 0.0 | 0.3 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.0 | 0.1 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
| 0.0 | 0.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.0 | 1.5 | GO:0005819 | spindle(GO:0005819) |
| 0.0 | 0.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.0 | 0.8 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
| 0.0 | 0.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.0 | 0.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.0 | 1.9 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.0 | 7.5 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.5 | 9.9 | GO:0070052 | collagen V binding(GO:0070052) |
| 2.2 | 17.5 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 1.2 | 6.1 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
| 1.0 | 3.1 | GO:0016768 | spermine synthase activity(GO:0016768) |
| 0.9 | 5.5 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 0.9 | 4.6 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 0.9 | 2.6 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 0.7 | 2.1 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
| 0.7 | 3.4 | GO:0052829 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) inositol-1,3,4-trisphosphate 1-phosphatase activity(GO:0052829) |
| 0.6 | 15.5 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 0.6 | 1.9 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
| 0.6 | 7.5 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.6 | 0.6 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.6 | 2.4 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 0.6 | 0.6 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
| 0.6 | 2.3 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 0.6 | 3.9 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 0.5 | 10.4 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.5 | 2.1 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
| 0.5 | 3.9 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
| 0.4 | 3.1 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 0.4 | 0.4 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 0.4 | 0.8 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
| 0.4 | 7.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.4 | 1.2 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 0.4 | 2.3 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.4 | 1.5 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
| 0.4 | 56.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.4 | 7.7 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 0.3 | 6.5 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 0.3 | 2.7 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.3 | 1.7 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.3 | 1.3 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
| 0.3 | 0.6 | GO:0048185 | activin binding(GO:0048185) |
| 0.3 | 1.9 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.3 | 0.9 | GO:0005365 | myo-inositol transmembrane transporter activity(GO:0005365) |
| 0.3 | 2.8 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 0.3 | 2.8 | GO:0042610 | CD8 receptor binding(GO:0042610) |
| 0.3 | 0.9 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 0.3 | 9.8 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.3 | 0.9 | GO:0080122 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
| 0.3 | 1.5 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
| 0.3 | 0.9 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.3 | 1.1 | GO:1902379 | receptor tyrosine kinase-like orphan receptor binding(GO:0005115) chemoattractant activity involved in axon guidance(GO:1902379) |
| 0.3 | 1.1 | GO:0035501 | MH1 domain binding(GO:0035501) |
| 0.3 | 1.4 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
| 0.3 | 0.8 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
| 0.3 | 1.7 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.3 | 1.4 | GO:0034584 | piRNA binding(GO:0034584) |
| 0.3 | 2.2 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 0.3 | 1.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 0.3 | 12.9 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.3 | 5.4 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.3 | 1.3 | GO:0035500 | MH2 domain binding(GO:0035500) |
| 0.3 | 0.5 | GO:0035939 | microsatellite binding(GO:0035939) |
| 0.3 | 1.3 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
| 0.3 | 3.8 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
| 0.2 | 1.2 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 0.2 | 2.1 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
| 0.2 | 0.7 | GO:0001147 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
| 0.2 | 1.4 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
| 0.2 | 3.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.2 | 0.7 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
| 0.2 | 0.7 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
| 0.2 | 0.9 | GO:0016005 | phospholipase A2 activator activity(GO:0016005) |
| 0.2 | 2.7 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
| 0.2 | 0.8 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.2 | 4.9 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.2 | 1.4 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.2 | 2.8 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.2 | 1.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 0.2 | 0.6 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
| 0.2 | 3.5 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.2 | 4.2 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.2 | 1.1 | GO:0052845 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
| 0.2 | 0.9 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.2 | 2.0 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.2 | 1.0 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
| 0.2 | 1.5 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.2 | 1.8 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.2 | 7.3 | GO:0030546 | receptor activator activity(GO:0030546) |
| 0.2 | 5.6 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.2 | 2.1 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.2 | 2.3 | GO:0048156 | tau protein binding(GO:0048156) |
| 0.2 | 1.1 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
| 0.2 | 0.6 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 0.2 | 0.8 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
| 0.2 | 0.5 | GO:0047676 | arachidonate-CoA ligase activity(GO:0047676) |
| 0.2 | 10.1 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.2 | 0.5 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
| 0.2 | 0.6 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.2 | 0.6 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.1 | 0.6 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 0.1 | 2.0 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.1 | 0.4 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
| 0.1 | 4.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 0.1 | 2.2 | GO:0005003 | ephrin receptor activity(GO:0005003) |
| 0.1 | 0.4 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
| 0.1 | 7.1 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
| 0.1 | 2.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.1 | 1.0 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 0.1 | 8.7 | GO:0001221 | transcription cofactor binding(GO:0001221) |
| 0.1 | 1.1 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
| 0.1 | 3.1 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.1 | 1.9 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.1 | 3.0 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 0.1 | 1.2 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.1 | 0.9 | GO:0005522 | profilin binding(GO:0005522) |
| 0.1 | 1.6 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 0.1 | 0.4 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
| 0.1 | 0.2 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.1 | 1.9 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.1 | 2.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.1 | 1.9 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 0.1 | 2.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.1 | 4.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.1 | 0.5 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 0.1 | 0.3 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 0.1 | 0.2 | GO:0001083 | transcription factor activity, RNA polymerase II basal transcription factor binding(GO:0001083) |
| 0.1 | 1.1 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 0.1 | 2.5 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.1 | 1.8 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.1 | 2.3 | GO:0008430 | selenium binding(GO:0008430) |
| 0.1 | 1.1 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 0.1 | 0.7 | GO:0003983 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
| 0.1 | 2.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.1 | 0.9 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 0.1 | 1.4 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.1 | 0.4 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
| 0.1 | 6.8 | GO:0019894 | kinesin binding(GO:0019894) |
| 0.1 | 1.1 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
| 0.1 | 4.2 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.1 | 0.5 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.1 | 0.3 | GO:0004651 | polynucleotide 5'-phosphatase activity(GO:0004651) |
| 0.1 | 2.3 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
| 0.1 | 1.3 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.1 | 1.2 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
| 0.1 | 0.4 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 0.1 | 0.5 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
| 0.1 | 0.8 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
| 0.1 | 1.7 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 0.1 | 1.5 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.1 | 1.9 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.1 | 0.3 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
| 0.1 | 1.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.1 | 6.2 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.1 | 3.2 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.1 | 4.1 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.1 | 0.9 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.1 | 0.8 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
| 0.1 | 0.6 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.1 | 0.5 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 0.1 | 1.4 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.1 | 0.7 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 0.1 | 0.6 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.1 | 0.8 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 0.1 | 3.1 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 0.1 | 0.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.1 | 4.1 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.1 | 1.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.1 | 1.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.1 | 4.8 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 0.1 | 1.2 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.1 | 0.5 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.1 | 4.8 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.1 | 0.7 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
| 0.1 | 0.7 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.1 | 1.0 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
| 0.1 | 1.0 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.1 | 2.2 | GO:0032452 | histone demethylase activity(GO:0032452) |
| 0.1 | 0.8 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
| 0.1 | 0.4 | GO:0008144 | drug binding(GO:0008144) |
| 0.1 | 0.7 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.1 | 0.5 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.1 | 1.1 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.1 | 16.4 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.1 | 4.6 | GO:0031490 | chromatin DNA binding(GO:0031490) |
| 0.1 | 0.2 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
| 0.1 | 0.9 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.1 | 18.9 | GO:0051020 | GTPase binding(GO:0051020) |
| 0.1 | 1.0 | GO:0016208 | AMP binding(GO:0016208) |
| 0.1 | 1.2 | GO:0031005 | filamin binding(GO:0031005) |
| 0.1 | 1.9 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 0.1 | 3.4 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.1 | 1.0 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 0.1 | 12.3 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.1 | 0.3 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
| 0.1 | 0.6 | GO:0009374 | biotin carboxylase activity(GO:0004075) biotin binding(GO:0009374) |
| 0.1 | 0.3 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
| 0.1 | 1.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.1 | 0.7 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.1 | 4.5 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.0 | 2.0 | GO:0070888 | E-box binding(GO:0070888) |
| 0.0 | 0.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 0.0 | 1.4 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.0 | 0.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.0 | 1.2 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 0.0 | 5.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.0 | 1.6 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.0 | 2.7 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
| 0.0 | 0.5 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.0 | 0.1 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
| 0.0 | 2.1 | GO:0043022 | ribosome binding(GO:0043022) |
| 0.0 | 2.6 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.0 | 6.1 | GO:0008565 | protein transporter activity(GO:0008565) |
| 0.0 | 0.4 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.0 | 0.2 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 0.0 | 0.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.0 | 1.2 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.0 | 0.8 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.0 | 0.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.0 | 0.4 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 0.0 | 0.1 | GO:0004104 | acetylcholinesterase activity(GO:0003990) cholinesterase activity(GO:0004104) |
| 0.0 | 1.0 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.0 | 0.9 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.0 | 0.5 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
| 0.0 | 4.5 | GO:0043130 | ubiquitin binding(GO:0043130) |
| 0.0 | 1.5 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.0 | 0.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
| 0.0 | 0.7 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
| 0.0 | 1.7 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.0 | 1.7 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
| 0.0 | 0.4 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.0 | 1.1 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 0.0 | 0.8 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.0 | 0.5 | GO:0043295 | glutathione binding(GO:0043295) |
| 0.0 | 0.2 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
| 0.0 | 7.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.0 | 0.2 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.0 | 0.4 | GO:0098960 | postsynaptic neurotransmitter receptor activity(GO:0098960) |
| 0.0 | 0.7 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
| 0.0 | 0.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.0 | 0.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) protein histidine kinase activity(GO:0004673) |
| 0.0 | 0.2 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
| 0.0 | 0.1 | GO:0035473 | lipase binding(GO:0035473) |
| 0.0 | 0.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
| 0.0 | 0.4 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
| 0.0 | 3.4 | GO:0004386 | helicase activity(GO:0004386) |
| 0.0 | 3.1 | GO:0002020 | protease binding(GO:0002020) |
| 0.0 | 0.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.0 | 0.6 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.0 | 0.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.0 | 2.7 | GO:0047485 | protein N-terminus binding(GO:0047485) |
| 0.0 | 0.7 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.0 | 1.0 | GO:0004407 | histone deacetylase activity(GO:0004407) |
| 0.0 | 0.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.0 | 0.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 0.0 | 0.6 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
| 0.0 | 1.2 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
| 0.0 | 0.5 | GO:0030371 | translation repressor activity(GO:0030371) |
| 0.0 | 0.6 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
| 0.0 | 0.4 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 0.0 | 2.5 | GO:0051082 | unfolded protein binding(GO:0051082) |
| 0.0 | 0.1 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
| 0.0 | 1.6 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
| 0.0 | 0.5 | GO:0043531 | ADP binding(GO:0043531) |
| 0.0 | 0.4 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
| 0.0 | 0.2 | GO:0016004 | phospholipase activator activity(GO:0016004) |
| 0.0 | 0.7 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
| 0.0 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
| 0.0 | 0.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.0 | 0.2 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
| 0.0 | 0.3 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
| 0.0 | 0.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.0 | 0.0 | GO:0090541 | MIT domain binding(GO:0090541) |
| 0.0 | 0.1 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.0 | 0.3 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
| 0.0 | 0.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.0 | 0.5 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.0 | 0.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
| 0.0 | 0.0 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
| 0.0 | 0.2 | GO:0008143 | poly(A) binding(GO:0008143) |
| 0.0 | 1.7 | GO:0004896 | cytokine receptor activity(GO:0004896) |
| 0.0 | 0.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.0 | 0.1 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
| 0.0 | 0.2 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.4 | 9.8 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.3 | 25.1 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.3 | 20.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.3 | 2.0 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
| 0.3 | 5.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.2 | 0.9 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.2 | 1.8 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.2 | 7.9 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.2 | 8.9 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
| 0.2 | 1.9 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.2 | 2.4 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.2 | 2.9 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.2 | 6.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.2 | 13.1 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 0.2 | 5.4 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.2 | 2.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.2 | 8.8 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.2 | 22.2 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.2 | 13.7 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.2 | 3.8 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.1 | 3.0 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 0.1 | 0.7 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.1 | 3.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.1 | 0.7 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.1 | 1.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.1 | 7.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.1 | 5.5 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.1 | 3.3 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.1 | 1.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.1 | 0.9 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.1 | 1.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.1 | 5.4 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.1 | 4.4 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.1 | 19.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.1 | 2.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.1 | 3.0 | PID SHP2 PATHWAY | SHP2 signaling |
| 0.1 | 4.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.1 | 2.4 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.1 | 4.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.1 | 0.3 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
| 0.1 | 0.7 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
| 0.0 | 0.9 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.0 | 2.8 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.0 | 0.5 | PID ERBB4 PATHWAY | ErbB4 signaling events |
| 0.0 | 2.2 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.0 | 2.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.0 | 2.3 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.0 | 3.7 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.0 | 0.7 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
| 0.0 | 4.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.0 | 0.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.0 | 0.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.0 | 0.7 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
| 0.0 | 0.9 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.0 | 2.6 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.0 | 2.8 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.0 | 1.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.0 | 2.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.0 | 2.4 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.0 | 0.7 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.0 | 0.8 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 0.0 | 1.9 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.0 | 0.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.0 | 0.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.0 | 0.9 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
| 0.0 | 0.4 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
| 0.0 | 1.1 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.0 | 0.8 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.0 | 1.6 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.0 | 0.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.0 | 0.3 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.0 | 0.5 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.0 | 0.4 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.0 | 1.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.0 | 0.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
| 0.0 | 0.5 | PID ATR PATHWAY | ATR signaling pathway |
| 0.0 | 0.5 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.0 | 0.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.0 | 0.6 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.3 | 7.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
| 0.3 | 1.3 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 0.3 | 4.6 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 0.3 | 5.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.2 | 6.0 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.2 | 0.9 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
| 0.2 | 9.5 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.2 | 4.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.2 | 3.7 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.2 | 4.5 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 0.2 | 5.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.2 | 19.1 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.2 | 7.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.1 | 7.9 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.1 | 9.2 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.1 | 4.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.1 | 2.2 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
| 0.1 | 3.8 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.1 | 4.4 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
| 0.1 | 0.7 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
| 0.1 | 1.9 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 0.1 | 4.8 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.1 | 1.2 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
| 0.1 | 2.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.1 | 1.3 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.1 | 2.0 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.1 | 5.7 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
| 0.1 | 2.0 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.1 | 2.7 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
| 0.1 | 1.6 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.1 | 5.8 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.1 | 0.1 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
| 0.1 | 12.5 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
| 0.1 | 0.9 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
| 0.1 | 1.8 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.1 | 10.9 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.1 | 0.8 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
| 0.1 | 12.1 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
| 0.1 | 0.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.1 | 2.0 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
| 0.1 | 2.2 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.1 | 1.0 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
| 0.1 | 3.2 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.0 | 4.3 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.0 | 0.9 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
| 0.0 | 1.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.0 | 1.0 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 0.0 | 3.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.0 | 0.8 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 0.0 | 1.0 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
| 0.0 | 0.7 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
| 0.0 | 1.5 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.0 | 3.9 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.0 | 1.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.0 | 0.9 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.0 | 3.5 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
| 0.0 | 0.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.0 | 0.7 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.0 | 1.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
| 0.0 | 2.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.0 | 0.9 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.0 | 0.8 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 0.0 | 0.2 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.0 | 1.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.0 | 0.8 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
| 0.0 | 0.8 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 0.0 | 7.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.0 | 5.0 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
| 0.0 | 0.9 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.0 | 0.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.0 | 1.1 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.0 | 1.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.0 | 1.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.0 | 0.4 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
| 0.0 | 0.3 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
| 0.0 | 0.7 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.0 | 0.7 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.0 | 1.0 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.0 | 0.7 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.0 | 0.9 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| 0.0 | 0.5 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.0 | 0.3 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.0 | 0.2 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
| 0.0 | 0.8 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 0.0 | 0.9 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.0 | 0.2 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
| 0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 0.0 | 0.4 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.0 | 0.4 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
| 0.0 | 1.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.0 | 0.7 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.0 | 0.4 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.0 | 0.2 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.0 | 0.2 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
| 0.0 | 0.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.0 | 0.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.0 | 1.0 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
| 0.0 | 0.4 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.0 | 0.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.0 | 0.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |